AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 NOV 14 - (NewsRx.com & NewsRx.net) -- The U.S. Preventive Services Task Force has recommended against the use of combined estrogen and progestin therapy for preventing cardiovascular disease and other chronic conditions in postmenopausal women.
The recommendations are posted on the web sites of Annals of Internal Medicine (www.acponline.org/journals/annals/hrt.htm) and the Agency for Healthcare Research and Quality and will be published in the November 19, 2002, issue of the journal.
The Task Force, an independent panel of private-sector experts in prevention and primary care sponsored by the Agency for Healthcare Research and Quality, found evidence for both benefits and harms of combined estrogen and progestin therapy, one of the most commonly prescribed hormone regimens. However, it concluded that harmful effects of the combined therapy are likely to exceed the chronic-disease prevention benefits for most women.
The Task Force further concluded that the evidence is insufficient to recommend for or against the use of estrogen alone for prevention of chronic conditions in postmenopausal women who have had hysterectomies. A study of estrogen therapy in these women is continuing as part ...
Source: HighBeam Research, Task force issues caution on combined hormone therapy.(U.S....